A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS)

OBJECTIVES: Although the painful and disabling features of early diffuse cutaneous SSc (dcSSc) have an inflammatory basis and could respond to corticosteroids, corticosteroids are a risk factor for scleroderma renal crisis. Whether or not they should be prescribed is therefore highly contentious. Ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffiths-Jones, Deborah J, Garcia, Yvonne Sylvestre, Ryder, W David, Pauling, John D, Hall, Frances, Lanyon, Peter, Bhat, Smita, Douglas, Karen, Gunawardena, Harsha, Akil, Mohammed, Anderson, Marina, Griffiths, Bridget, Del Galdo, Francesco, Youssef, Hazem, Madhok, Rajan, Arthurs, Barbara, Buch, Maya, Fligelstone, Kim, Zubair, Mohammed, Mason, Justin C, Denton, Christopher P, Herrick, Ariane L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473191/
https://www.ncbi.nlm.nih.gov/pubmed/36637209
http://dx.doi.org/10.1093/rheumatology/kead012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473191/
https://www.ncbi.nlm.nih.gov/pubmed/36637209
http://dx.doi.org/10.1093/rheumatology/kead012

Ejemplares similares